Design variants
How many distinct Blue Punisher designs are in the data?
— distinct press variants identified so far by hand-sorting — pill images visually. Every cluster below contains only pills explicitly placed into it during the manual sort — no image-similarity inference. As more pills are hand-sorted the clusters grow.
The Punisher skull is iconic and easy to copy — anyone with a press can stamp one. Variants differ in skull rendering, embossing depth, presence of "THE PUNISHER" text, the break score on the back, and physical dimensions. Colour is just one axis — blue dominates, but pink, green, grey, purple, yellow and red Punishers also exist with similarly varied content. Same logo — a different press behind every variant.
— reports outside the hand-sort — grouped by colour/country/source (descriptive, not press-die clusters)
These records report a Punisher but haven't been hand-placed into a visual cluster (mostly because their source doesn't have image vectors we can match). They're bucketed by what metadata we have — colour, country, source — purely for context. They are not a claim about press-die identity.
Timeline
When did the Blue Punisher hype start?
The first Punisher submission in our data is from —. Volume exploded after November 2021, when Manchester Metropolitan University's Mandrake drug-analysis lab tested a Blue Punisher containing 477mg MDMA — about four times a standard recreational dose.¹
The Punisher logo is much older than the "Blue Punisher" hype. The earliest Punisher entries in our data are from 2007 — submitted to PillReports from the 🇺🇸 US (Louisiana, Chicago, Detroit, southern California) and 🇨🇦 British Columbia. Even a "Blue Punisher" appears in So Cal in October 2007. The skull logo has been pressed onto pills for nearly two decades; what's specific to recent years is the iconic blue high-dose variant.
The existing "Rise of the Punisher" section on this site frames it as a 2020 Barcelona phenomenon. That reflects when EU harm-reduction testing services (Checkit, EnergyControl, Saferparty) scaled up — not when the pill appeared. Vienna's Checkit started seeing Punishers steadily from 2020, and that's what the existing chart captures.
What did change in late 2021 was global press attention. The Manchester 477mg lab result was picked up by Vice, Dazed, Mixmag, Drugs.ie and dozens of nightlife outlets. Quarterly Punisher submissions roughly doubled in the four quarters after the incident.
Dose erosion
The post-hype Punisher is fundamentally weaker
Pre-2021 Punishers averaged — mg of MDMA. After the late-2021 press attention put the pill on the front page, the typical Punisher dropped to — mg and has stayed there — a — change at the median, across — post-press tests.
Same logo. Same colour. Different product. The 2017–2020 plateau sat at roughly 240 mg per pill — high but consistent. Once the Manchester Mandrake 477 mg story hit Mixmag and Vice, the market flooded with copycat presses and the median collapsed to ~150 mg. The dot spread within each year (25th–75th percentile band) is wider too — buyers are now getting anything from a featherweight to an old-style bomb, with no way to tell from the pill.
Solid line = median MDMA mg per year. Shaded band = 25th–75th percentile range. n per year shown along the x-axis. 2017–2020 data is sparse (n=3–31); from 2021 onward every year has 100+ measurements.
Is this statistically defensible?
Yes. Direct hypothesis tests on the raw measurements (not the yearly medians) reject "the pre and post distributions are the same" with virtually zero probability:
- Mann–Whitney U (non-parametric, doesn't assume normality): p = —
- Welch's t-test: t = —, p = —
- Cohen's d (effect-size on means): — — "very large" by convention (> 0.8)
And — most importantly — the drop reproduces within every individual lab that has data on both sides of the 2021 inflection. Same methodology, same submission pipeline, just before vs after:
Caveat: harm-reduction services test what users send in. If buyers started submitting pills more often when they were surprised by weakness (a plausible reaction to the "strongest-ever" hype framing), some of the apparent erosion could be selection bias on the input side. The within-source consistency makes this less likely as a full explanation, but it can't be fully ruled out without a controlled buy-and-test programme. Worth disclosing.
Dose range
How much MDMA is actually in a Blue Punisher?
MDMA content within Punisher pills in our data ranges from — to —. Even within a single visual cluster, the spread is large.
A standard recreational dose is around 80–125mg MDMA. 125–180mg is high-dose territory; above 180mg is very high; above 250mg is an extreme dose with serious risk of hyperthermia and serotonin syndrome. The Manchester 477mg pill ¹ sits well outside the in-database range — but pills above 250mg are not rare within our data. The "Extra edge" press die is ~76% stronger at the median than "No nose" — buyers can't tell from looking, but there is a real dose hierarchy across visual variants.
Each box shows the distribution of MDMA content within one visual cluster. Bottom whisker = minimum, box = 25th–75th percentile (median bar inside), top whisker = maximum. Red star marks the external Manchester 477mg report.
Closer look
Weakest vs strongest Blue Punishers — and the batch question
Same blue skull, same logo, same color. The pills below contain almost no MDMA on the left, and high enough doses to send most users to the emergency room on the right. The scatter below plots every Blue Punisher we have a date and a dose for — do clusters of high or low doses appear in specific time periods? When the spread within a single month widens, a new batch is likely circulating alongside the old.
Weakest 6 (in our data)
Strongest 6 (in our data)
Dose over time
Each dot is one Blue Punisher whose pill image was manually verified against a press-die cluster in the sort tool — i.e. we eyeballed it and assigned it. Auto-matched pills are excluded so the cluster colours below aren't inferred. Dot colour = visual cluster (matching Q1). Hover for the pill image and test details. Where dots bunch in time at similar doses, that's a likely batch.
Popularity
Have Blue Punishers gotten more or less popular?
Raw counts can mislead — Checkit and Saferparty only started reporting at scale around 2020, so part of the post-2021 "rise" reflects services growing, not Punishers spreading. The cleaner metric is share of MDMA tests at each service.
—
Geography
Where are the strongest Blue Punishers found?
Cities with the highest mean MDMA content among Punisher pills tested locally, minimum 5 reports per city. Toggle to see peak doses instead of averages. Vienna alone accounts for —% of all geo-tagged Punisher tests — and Vienna + Barcelona together = —%. The Punisher is dominantly a Central-European story in testing data — but that concentration partly reflects where high-volume drug-checking services operate (Checkit in Vienna, EnergyControl in Spain), not a measured prevalence difference between cities. Cities without a walk-in testing service barely register here regardless of what circulates locally.
🇬🇧 Manchester, UK — outside the test-service data
In November 2021, Manchester Metropolitan University's Mandrake Lab tested a Blue Punisher seized in Manchester nightclubs and recorded 477mg MDMA — part of a batch ranging 397–477mg. That pill never reached a harm-reduction testing service. It is not in the bars above. It is the data point that triggered the global Blue Punisher panic.¹
Myth vs reality
What happens when one design gets global hype?
A logo becomes a brand. A brand becomes a shortcut. A shortcut becomes a dangerous assumption about strength and purity.
Myth
- "Blue Punisher means strong MDMA"
- "Same logo = same pill, everywhere"
- "You can identify clean pills by color"
- "If it's blue, it's the famous one"
Reality in this data
- MDMA range: — in services; up to 477mg in lab seizures¹
- — distinct visual press variants — same logo, different presses
- — Punisher-logo samples contained no measurable MDMA, or had it cut with caffeine / amphetamine / synthesis impurities
- Only —% of Punisher samples have confirmed blue color — pink, green, grey, yellow, purple, red Punishers exist too, with similar dose variance
Case study: the 477 mg Mandrake pill
Visually this pill matches the "No nose" press die — the same family as — other hand-verified Punishers in our data. Pills from that die typically contain — mg of MDMA. This one contained 477 mg — over three times the typical dose, and well outside any plausible random variation:
A 10σ event under a normal distribution has astronomical odds against — meaning this pill is not a slightly-stronger version of the cluster's usual output. Most likely the same press die was reused with a much hotter MDMA blend (e.g. a single production run that bypassed the binder dilution step). Same skull, same colour, same press — over 3× the dose. This is the central reason "Blue Punisher" doesn't mean anything about strength or purity: the buyer holds an identical-looking pill but has no idea which slice of the dose curve they got.
Press-die archaeology — documented before vs after the press wave
Each row below is one visual press-die cluster from Q1. Bar = the period we have hand-verified samples for that design; dot = the quarter with the most submissions. The dashed pink line is the November 2021 press inflection (Mixmag + Vice). Designs whose first hand-verified appearance sits LEFT of the line were already circulating pre-press; those first appearing to the RIGHT are post-press arrivals that surfaced after the Punisher made the front page. — pre-press designs, — post-press designs.
Caveat: "first seen" is a lower bound — a press die might have existed in the market earlier but only got tested when the hype brought more pills into harm-reduction services. Read this as "we can vouch the design existed by date X", not "the design was created on date X". Hover any row for details.
Same logo, any dose — the full spread
Every measured Punisher in this dataset — all colours — binned by MDMA content. A standard recreational dose is around 80–125 mg. 125–180 mg is "high dose"; above 180 mg is very high; above 250 mg risks hyperthermia and serotonin syndrome. You cannot tell from looking at the pill which slice of this curve it falls into.
Each bar = number of pills in that 25 mg bracket. Coloured bands show recreational (green) / high (amber) / very high (red) / extreme (dark red) dose territory.
"The dose makes the poison. A skull on a pill does not tell you the dose." — Drug-checking principle, applied here to the Punisher
What the testing services actually said about real Punishers
By country
What design dominates in each country?
The Punisher is one design among many. For each country with enough MDMA tests since 2021, here are the top pill designs reported locally, with Punisher highlighted where it appears.
For each country with enough MDMA tests since 2021, the most-reported design is shown as the hero photo, followed by ranks #2–7 in descending tile size. The Punisher is highlighted in accent colour wherever it appears — letting you see at a glance which markets were Punisher-dominant and which treat it as just another pill in a crowded catalogue. Whatever a pill called itself, the dose still varied. The takeaway: brand identity ≠ pill identity ≠ safety. Click any image to zoom.